Literature DB >> 24376145

Reversing effect of sorcin in the drug resistance of human nasopharyngeal carcinoma.

Xuebing Liu1, Lei Chen, Bin Feng, Gang Liu.   

Abstract

Nasopharyngeal carcinoma (NPC) is one of the most common cancers originating in the nasopharynx, and chemoresistance is an essential aspect of NPC chemotherapy failure. Sorcin has been implicated in multidrug resistance (MDR) of many types of human tumor. However, the effect and mechanism of Sorcin in MDR of human NPC is not fully clear. In this report, we silenced Sorcin in human NPC CNE2/DDP cells, and explored the role of Sorcin in MDR reversal. The results showed an increased cytotoxicity of cisplatin and intracellular accumulation of Rhodamine-123 and glutathione depletion in Sorcin silencing CNE2/DDP cells. We also found a decreased messenger RNA and protein expression of multidrug resistance gene (MDR1), multidrug resistance-associated protein (MRP1), excision repair cross-complementing gene 1 (ERCC1), glutathione S-transferase-π (GST-n), RhoE, Bcl-2, and Survivin in Sorcin silencing CNE2/DDP cells. The increased expression of PTEN and decreased expression of p-Akt and NF-κB suggested that the key cellular signaling pathways were triggered by Sorcin silencing. We concluded that Sorcin silencing would contribute to establish a potent target point for MDR reversal.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  multidrug resistance; nasopharyngeal carcinoma; sorcin

Mesh:

Substances:

Year:  2013        PMID: 24376145     DOI: 10.1002/ar.22832

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  9 in total

Review 1.  Pathophysiological Functions of Rnd3/RhoE.

Authors:  Wei Jie; Kelsey C Andrade; Xi Lin; Xiangsheng Yang; Xiaojing Yue; Jiang Chang
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

2.  iTRAQ-based quantitative proteomic analysis of differentially expressed proteins in chemoresistant nasopharyngeal carcinoma.

Authors:  Kun Wang; Zhen Chen; Lu Long; Ya Tao; Qiong Wu; Manlin Xiang; Yunlai Liang; Xulin Xie; Yuan Jiang; Zhiqiang Xiao; Yahui Yan; Shiyang Qiu; Bin Yi
Journal:  Cancer Biol Ther       Date:  2018-08-01       Impact factor: 4.742

3.  Niflumic acid exhibits anti-tumor activity in nasopharyngeal carcinoma cells through affecting the expression of ERK1/2 and the activity of MMP2 and MMP9.

Authors:  Shengqun Luo; Guoliang Huang; Ziyou Wang; Zheng Wan; Hua Chen; Dan Liao; Chuyan Chen; Huahui Li; Binbin Li; Liyong Chen; Zunnan Huang; Zhiwei He
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 4.  Mitochondria: Insights into Crucial Features to Overcome Cancer Chemoresistance.

Authors:  Ilaria Genovese; Marianna Carinci; Lorenzo Modesti; Gianluca Aguiari; Paolo Pinton; Carlotta Giorgi
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

5.  Loss of AKR1C1 is a good prognostic factor in advanced NPC cases and increases chemosensitivity to cisplatin in NPC cells.

Authors:  Chen Zhou; Guowen Shen; Fan Yang; Jingling Duan; Zhen Wu; Mingqing Yang; Yi Liu; Xueli Du; Xiaoling Zhang; Shengjun Xiao
Journal:  J Cell Mol Med       Date:  2020-04-19       Impact factor: 5.310

6.  Binding of doxorubicin to Sorcin impairs cell death and increases drug resistance in cancer cells.

Authors:  Ilaria Genovese; Annarita Fiorillo; Andrea Ilari; Silvia Masciarelli; Francesco Fazi; Gianni Colotti
Journal:  Cell Death Dis       Date:  2017-07-20       Impact factor: 8.469

7.  Sorcin: a novel potential target in therapies of cancers.

Authors:  Xinyi Zhou; Xue Wu; Baoan Chen
Journal:  Cancer Manag Res       Date:  2019-08-05       Impact factor: 3.989

8.  Broad regulation of gene isoform expression by Wnt signaling in cancer.

Authors:  Muhammad Idris; Nathan Harmston; Enrico Petretto; Babita Madan; David M Virshup
Journal:  RNA       Date:  2019-09-10       Impact factor: 4.942

Review 9.  Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target.

Authors:  Theo Battista; Annarita Fiorillo; Valerio Chiarini; Ilaria Genovese; Andrea Ilari; Gianni Colotti
Journal:  Cancers (Basel)       Date:  2020-04-06       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.